16681-65-5, name is 1-Methyl-1H-1,2,3-triazole, belongs to Triazoles compound, is considered to be a conventional heterocyclic compound, which is widely used in drug synthesis. The chemical synthesis route is as follows. 16681-65-5
Example 65a: (4-chloro-3-(4-fluorobenzyl)-2-methoxyquinolin-6-yl)(1,2-dimethyl-1H-imidazol-5-yl)(1-methyl-1H-1,2,3-triazol-5-yl)methanol A. solution of -BuLi (2.5 M in hexanes, 1.5 mL, 3.75 mmol) was added dropwise by syringe to a solution of 1 -methyl- 1H- 1 ,2,3-triazole (324 mg, 3.90 mmol) in dry THF (20 mL) in a dry ice- methanol bath. The suspension was stirred for 30 minutes, slowly allowing the reaction mixture to warm to -20 C. (4-CWoro-3-(4-fluorobenzyl)-2-methoxyquinolin-6-yl)(l ,2-dimethyl-lH- imidaz.ol-5-yl)methanone (0.800 g, 1.89 mmol, Intermediate 46: step b) in dry THF (10 ml.) was added to the mixture via syringe and the resulting mixture was allowed to warm to ambient temperature overnight. The reaction was quenched with saturated aqueous ammonium chloride. Water was added and the aqueous mixture was extracted with dichloromethane. The combined organic layers were dried (Na2S04), filtered, and concentrated to dryness. The crude product was purified by flash column chromatography (silica gel, 0-5% MeOH-DCM) to provide the title compound, NMR (400 MHz, CDCk) 5 8.24 (d, ./ = 1.9 Hz, i l l). 8.05 (s, 1H), 7.71 (d, ./ = 8.7 Hz, 1H), 7.37 (dd, J = 8.7, 2.0 Hz, 1H), 7.26 – 7.21 (m, 2H), 7.02 (s, 1H), 6.97 – 6.90 (m, 21 1). 5.95 (s, 1H), 4.16 (s, 2H), 4.07 (s, 3H), 3.87 (s, 3H), 3.31 (s, 3H), 2.09 (s, 3H); MS m/e 506.9 i M I .Example 65s was purified by chiral SFC (ChiralPai AD-H, 75:25 C02:MeOH + 0.3% ?PrNH2) to provide two pure enantiomers. The first eluting enantiorner was Example 65b: NMR. (400 MHz, CDC13) 6 8.23 – 8.19 (d, J = 2.1 Hz, 1H), 7.73 – 7.68 (d, J = 8.7 Hz, 1H), 7.39 – 7.33 (dd, J = 8.8, 2.2 Hz, 1 H), 7.29 – 7.23 (m, 2H), 7.07 (s, 1H), 6.98 – 6.91 (m, 2H), 6.47 (br s, 1 H), 6.03 (s, H I). 4.21 (s, 2H), 4.07 (s, 3H), 3.89 (s, M l ). 3.34 (s, 3H), 2.20 (s, 3H); MS m/e 506.2 [M]+. The second eluting enantiorner was Example 65c: 1H NMR (400 MHz, CDCI3) delta 8.19 (d, J = 2.1 Hz, 1H), 7.72 (d, J = 8.7 Hz, 1 H), 7.36 (dd, J = 8.7, 2.2 Hz, 1H), 7.29 – 7.24 (m, 2H), 7.1 1 (s, 1H), 6.97 – 6.91 (m, 2H), 6.06 (s. I I I). 4.23 (s, 2H), 4.08 (s, 3H), 3.90 (s, 3H), 3.36 (s, 3H), 2.24 (s, 3H); MS m/e 506.2 [M]”
Statistics shows that 16681-65-5 is playing an increasingly important role. we look forward to future research findings about 1-Methyl-1H-1,2,3-triazole.
Reference:
Patent; JANSSEN PHARMACEUTICA NV; LEONARD, Kristi A.; BARBAY, Kent; EDWARDS, James P.; KREUTTER, Kevin D.; KUMMER, David A.; MAHAROOF, Umar; NISHIMURA, Rachel; URBANSKI, Maud; VENKATESAN, Hariharan; WANG, Aihua; WOLIN, Ronald L.; WOODS, Craig R.; FOURIE, Anne; XUE, Xiaohua; CUMMINGS, Maxwell D.; JONES, William Moore; GOLDBERG, Steven; WO2015/57205; (2015); A1;,
1,2,3-Triazole – Wikipedia,
Triazoles – an overview | ScienceDirect Topics